Viewing Study NCT01558232


Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2026-02-20 @ 12:27 PM
Study NCT ID: NCT01558232
Status: TERMINATED
Last Update Posted: 2012-07-09
First Post: 2012-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Prospective Study to Evaluate Use of the Tibion Bionic Leg in Sub-Acute Post-stroke Patients
Sponsor: Tibion Bionics, Inc.
Organization:

Study Overview

Official Title: A Prospective, Experimental ABA Study to Evaluate Use of the Tibion Bionic Leg in Subacute Post-stroke Patients Undergoing Physical Therapy
Status: TERMINATED
Status Verified Date: 2012-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Study was terminated base on Sponsor's decision.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Acute Effects
Brief Summary: The objective of this clinical study is to examine acute changes in stability, force allocation, work, and mobility from using a wearable, portable, battery-operated robotic orthosis (the Tibion Bionic Leg) in subacute post-stroke persons undergoing lower extremity physical therapy.
Detailed Description: Samples text.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: